市場調査レポート

商品コード

1422065

in situハイブリダイゼーションの世界市場：製品タイプ別、技術別、プローブタイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

In situ Hybridization Market Assessment, By Product Type, By Technology, By Probe Type, By Application, By End-Users, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年02月07日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 224 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のin situハイブリダイゼーションの市場規模は2023年に16億4,000万米ドルとなりました。同市場は、2031年には35億3,000万米ドルに達すると予測され、2024年から2031年の予測期間のCAGRは10.04%になるとみられています。世界のin situハイブリダイゼーション市場は非常にダイナミックで有望であり、堅調な製品と有利な市場戦術を有しています。in-situハイブリダイゼーション市場は、がん患者や遺伝性疾患の有病率の増加、研究開発におけるin-situハイブリダイゼーション技術の使用事例の増加、分子生物学やゲノミクスの進歩などの要因によって牽引されると予想されます。

がんのような疾患の診断と管理におけるin situハイブリダイゼーション技術の有効性が証明されたことで、ヘルスケア専門家による採用が拡大しました。いくつかの研究機関が、in situハイブリダイゼーションの可能性を探るために、ここ数年、大規模な調査を行っています。それは研究開発のシナリオを強化し、そのような製品に対する需要の著しい成長につながっています。それゆえ、世界中でがん患者が増加していることは、in situハイブリダイゼーション技術ががん細胞や遺伝子変異を検出するのに非常に効率的であるため、需要を促進する大きな要因となっています。しかし、製品に関連する高コスト、熟練した専門家の不足、複雑なデータの解釈が、世界のin situハイブリダイゼーション市場の成長を妨げる要因となっています。

当レポートでは、世界のin situハイブリダイゼーション市場について調査し、市場の概要とともに、製品タイプ別、技術別、プローブタイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 4. Global In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 5. Global In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 6. Global In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 7. Global In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 8. Global In situ Hybridization Market Share (%), By Region, 2017-2031F
Figure 9. North America In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 11. North America In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 12. North America In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 13. North America In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 14. North America In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 15. North America In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 16. North America In situ Hybridization Market Share (%), By Country, 2017-2031F
Figure 17. United States In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 19. United States In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 20. United States In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 21. United States In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 22. United States In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 23. United States In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 24. Canada In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 26. Canada In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 27. Canada In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 28. Canada In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 29. Canada In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 30. Canada In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 31. Mexico In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 33. Mexico In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 34. Mexico In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 35. Mexico In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 36. Mexico In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 37. Mexico In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 38. Europe In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 40. Europe In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 41. Europe In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 42. Europe In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 43. Europe In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 44. Europe In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 45. Europe In situ Hybridization Market Share (%), By Country, 2017-2031F
Figure 46. Germany In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 48. Germany In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 49. Germany In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 50. Germany In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 51. Germany In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 52. Germany In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 53. France In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 54. France In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 55. France In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 56. France In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 57. France In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 58. France In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 59. France In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 60. Italy In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 62. Italy In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 63. Italy In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 64. Italy In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 65. Italy In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 66. Italy In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 67. United Kingdom In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 69. United Kingdom In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 70. United Kingdom In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 71. United Kingdom In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 72. United Kingdom In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 73. United Kingdom In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 74. Russia In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 76. Russia In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 77. Russia In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 78. Russia In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 79. Russia In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 80. Russia In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 81. Netherlands In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 83. Netherlands In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 84. Netherlands In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 85. Netherlands In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 86. Netherlands In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 87. Netherlands In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 88. Spain In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 90. Spain In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 91. Spain In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 92. Spain In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 93. Spain In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 94. Spain In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 95. Turkey In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 97. Turkey In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 98. Turkey In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 99. Turkey In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 100. Turkey In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 101. Turkey In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 102. Poland In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 104. Poland In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 105. Poland In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 106. Poland In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 107. Poland In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 108. Poland In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 109. South America In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 111. South America In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 112. South America In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 113. South America In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 114. South America In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 115. South America In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 116. South America In situ Hybridization Market Share (%), By Country, 2017-2031F
Figure 117. Brazil In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 119. Brazil In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 120. Brazil In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 121. Brazil In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 122. Brazil In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 123. Brazil In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 124. Argentina In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 126. Argentina In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 127. Argentina In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 128. Argentina In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 129. Argentina In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 130. Argentina In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 131. Asia-Pacific In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 133. Asia-Pacific In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 134. Asia-Pacific In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 135. Asia-Pacific In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 136. Asia-Pacific In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 137. Asia- Pacific In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 138. Asia-Pacific In situ Hybridization Market Share (%), By Country, 2017-2031F
Figure 139. India In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 140. India In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 141. India In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 142. India In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 143. India In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 144. India In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 145. India In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 146. China In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 147. China In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 148. China In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 149. China In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 150. China In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 151. China In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 152. China In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 153. Japan In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 155. Japan In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 156. Japan In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 157. Japan In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 158. Japan In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 159. Japan In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 160. Australia In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 162. Australia In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 163. Australia In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 164. Australia In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 165. Australia In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 166. Australia In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 167. Vietnam In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 169. Vietnam In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 170. Vietnam In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 171. Vietnam In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 172. Vietnam In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 173. Vietnam In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 174. South Korea In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 176. South Korea In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 177. South Korea In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 178. South Korea In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 179. South Korea In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 180. South Korea In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 181. Indonesia In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 183. Indonesia In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 184. Indonesia In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 185. Indonesia In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 186. Indonesia In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 187. Indonesia In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 188. Philippines In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 190. Philippines In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 191. Philippines In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 192. Philippines In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 193. Philippines In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 194. Philippines In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 195. Middle East & Africa In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 197. Middle East & Africa In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 198. Middle East & Africa In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 199. Middle East & Africa In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 200. Middle East & Africa In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 201. Middle East & Africa In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 202. Middle East & Africa In situ Hybridization Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 205. Saudi Arabia In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 206. Saudi Arabia In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 207. Saudi Arabia In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 208. Saudi Arabia In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 209. Saudi Arabia In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 210. UAE In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 212. UAE In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 213. UAE In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 214. UAE In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 215. UAE In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 216. UAE In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 217. South Africa In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
Figure 219. South Africa In situ Hybridization Market Share (%), By Product Type, 2017-2031F
Figure 220. South Africa In situ Hybridization Market Share (%), By Technology, 2017-2031F
Figure 221. South Africa In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
Figure 222. South Africa In situ Hybridization Market Share (%), By Application, 2017-2031F
Figure 223. South Africa In situ Hybridization Market Share (%), By End-users, 2017-2031F
Figure 224. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Probe Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX10930

Global in situ hybridization market size was valued at USD 1.64 billion in 2023 and is expected to reach USD 3.53 billion in 2031, with a CAGR of 10.04% for the forecast period between 2024 and 2031F. The global in situ hybridization market is highly dynamic and promising, with a robust product and favorable market tactics. The in-situ hybridization market is expected to be driven by factors such as the increasing prevalence of cancer cases and genetic disorders, the growing use of in-situ hybridization techniques in research and development, and advancements in molecular biology and genomics.

The proven efficacy of in situ hybridization techniques in diagnosing and managing diseases like cancer led to their growing adoption by healthcare professionals. Several research organizations have spent the last few years conducting extensive research to explore possibilities around in situ hybridization. It has enhanced the research and development scenario and led to significant growth in demand for such products. Hence, growing cancer cases across the globe is a major factor driving the demand for in situ hybridization techniques as it is highly efficient in detecting cancerous cells and genetic mutations. However, the high cost associated with products, lack of highly skilled professionals, and interpretation of complicated data are some hindrances in the growth of the global in situ hybridization market.

In May 2023, Bio-Techne announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio with the commercialization of RNAscope multi-omic workflow for the Standard BioTools Hyperion Imaging System.

Bio-Techne is an international life sciences firm providing innovative tools and bioactive reagents for research and clinical diagnostics. The RNAscope is considered the gold standard for in situ hybridization and is trusted by biotechnological researchers worldwide, with a rapidly growing list of over 8,000 peer-reviewed publications.

Increasing Prevalence of Cancer Cases and Genetic Disorders

In situ hybridization techniques are used in genetic testing for cancers. These techniques help to detect chromosomal changes in patients and help healthcare professionals to identify the type of cancer, based on which the treatment is designed. Due to vast applications of in situ hybridization, techniques in the diagnosis of cancers and other genetic diseases are further driving the demand in the market. Besides cancers, in situ hybridization techniques are extensively utilized to diagnose other indications like infectious, viral, and immunological diseases. The American Society of Cancer estimates that 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. Cancer Research UK estimates that there will be 28 million cancer cases per year by 2040. It states that the United Kingdom's incidence is ranked higher than 90% of the world.

Growing Research and Development

The global in situ hybridization market is positively impacted by increased research and development surrounding genome exploration, diagnostic research, and its other healthcare and life sciences applications. Over the past few decades, the human genome project has significantly contributed to the growing body of research concerning genetic explorations and life sciences research. The market is anticipated to rise significantly with the growing acceptance and application of in situ hybridization in diagnostic centers, hospitals, and institutional and academic research projects. To increase their worldwide presence, major companies in the market are pursuing tactics including new launches, mergers and acquisitions, and partnerships.

In February 2023, Molecular Instruments (MI), which is a biotech firm under the umbrella of the California Institute of Technology, launched HCR RNA-CISH. The product is expected to stimulate automated chromogenic in situ hybridization (ISH) workflows that depend on Bio-Techne's RNAscope. According to the company, HCR RNA-CISH kits offer twice the turnaround time and half the cost of any current chromogenic in situ hybridization (CISH) method, while delivering superior performance. HCR RNA-CISH has native support for IHC codetection and is fully compatible with all popular automation platforms.

Fluorescent in Situ Hybridization (FISH) is Expected to Dominate During Forecast Period

The fluorescent in situ hybridization (FISH) technique finds a vast range of usage in the diagnosis of congenital disorders like Down's syndrome and other genetic diseases including cancer detection and identification. The growing application areas of fluorescent in situ hybridization (FISH) and its growing demand due to the rising burden of cancers and other genetic diseases is expected to make the fluorescent in situ hybridization (FISH) segment dominate the in situ hybridization market. The COVID-19 pandemic significantly boosted in situ hybridization and several research was done on it. For instance, in September 2023, a group of researchers published a protocol in STAR protocol, for the detection of infectious SARS-CoV-2 virus at low levels through in situ hybridization techniques.

North America to Lead the Global In situ Hybridization Market

North America is anticipated to dominate the market with the highest value share regarding its significant investment in research and development, technical breakthroughs made by major companies, highly developed healthcare infrastructure, and well-established research environment in North American nations like the United States and Canada. The government's actions and initiatives to assist medication development, genetic exploration, and cancer treatment contribute to the market's growth.

Key Players Landscape and Outlook

Market players are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products using a variety of tactics. Companies are expanding the range of products they offer to gain market share. Industry participants are using a variety of growth methods, including collaborations, mergers and acquisitions, partnerships, product launches, and development of new solutions, to bolster their position in the market.

In October 2023, Ikonisys SA partnered with Biocare Medical to expand the FISH diagnostic product portfolio. Biocare Medical is a leading firm providing immunohistochemistry (IHC) and Fluorescent in situ hybridization (FISH) tools and reagents while Ikonisys SA specializes in early and accurate detection of cancer through its unique fully automated solution for medical diagnostic labs. This partnership focuses on expanding the global distribution of products of Ikonisys SA, especially, the low-volume Ikoniscope20 and high-volume Ikoniscope20max. Earlier, Biocare Medical acquired Empire Genomics to expand its offering to include over 1 million FISH probes.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global In Situ Hybridization Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product Type
- 4.2.1. Consumables
- 4.2.2. Instruments
- 4.2.3. Software
4.3. By Technology
- 4.3.1. Fluorescent in situ hybridization (FISH)
- 4.3.2. Chromogenic in situ hybridization (CISH)
4.4. By Probe Type
- 4.4.1. DNA
- 4.4.2. RNA
4.5. By Application
- 4.5.1. Oncology
- 4.5.2. Neurology
- 4.5.3. Cytology
- 4.5.4. Immunology
- 4.5.5. Infectious Diseases
- 4.5.6. Developmental Biology
- 4.5.7. Others
4.6. By End-Users
- 4.6.1. Hospitals and Diagnostic Organizations
- 4.6.2. Clinical Research Organizations
- 4.6.3. Academics and Research Institutions
- 4.6.4. Pharmaceutical and Biotechnology Companies
- 4.6.5. Others
4.7. By Region
- 4.7.1. North America
- 4.7.2. Europe
- 4.7.3. Asia Pacific
- 4.7.4. South America
- 4.7.5. Middle East & Africa
4.8. By Company Market Share (%), 2023

5. Global In situ Hybridization Market Outlook, 2017-2031F

5.1. North America
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product Type
  - 5.1.2.1. Consumables
  - 5.1.2.2. Instruments
  - 5.1.2.3. Software
- 5.1.3. By Technology
  - 5.1.3.1. Fluorescent in situ hybridization (FISH)
  - 5.1.3.2. Chromogenic in situ hybridization (CISH)
- 5.1.4. By Probe Type
  - 5.1.4.1. DNA
  - 5.1.4.2. RNA
- 5.1.5. By Application
  - 5.1.5.1. Oncology
  - 5.1.5.2. Neurology
  - 5.1.5.3. Cytology
  - 5.1.5.4. Immunology
  - 5.1.5.5. Infectious Diseases
  - 5.1.5.6. Developmental Biology
  - 5.1.5.7. Others
- 5.1.6. By End-Users
  - 5.1.6.1. Hospitals and Diagnostic Organizations
  - 5.1.6.2. Clinical Research Organizations
  - 5.1.6.3. Academics and Research Institutions
  - 5.1.6.4. Pharmaceutical and Biotechnology Companies
  - 5.1.6.5. Others
- 5.1.7. United States*
  - 5.1.7.1. Market Size & Forecast
  - 5.1.7.1.1. By Value
  - 5.1.7.1.2. By Volume
  - 5.1.7.2. By Product Type
  - 5.1.7.2.1. Consumables
  - 5.1.7.2.2. Instruments
  - 5.1.7.2.3. Software
  - 5.1.7.3. By Technology
  - 5.1.7.3.1. Fluorescent in situ hybridization (FISH)
  - 5.1.7.3.2. Chromogenic in situ hybridization (CISH)
  - 5.1.7.4. By Probe Type
  - 5.1.7.4.1. DNA
  - 5.1.7.4.2. RNA
  - 5.1.7.5. By Application
  - 5.1.7.5.1. Oncology
  - 5.1.7.5.2. Neurology
  - 5.1.7.5.3. Cytology
  - 5.1.7.5.4. Immunology
  - 5.1.7.5.5. Infectious Diseases
  - 5.1.7.5.6. Developmental Biology
  - 5.1.7.5.7. Others
  - 5.1.7.6. By End-Users
  - 5.1.7.6.1. Hospitals and Diagnostic Organizations
  - 5.1.7.6.2. Clinical Research Organizations
  - 5.1.7.6.3. Academics and Research Institutions
  - 5.1.7.6.4. Pharmaceutical and Biotechnology Companies
  - 5.1.7.6.5. Others
- 5.1.8. Canada
- 5.1.9. Mexico

All segments will be provided for all regions and countries covered:

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. South America
- 5.3.1. Brazil
- 5.3.2. Argentina
5.4. Asia-Pacific
- 5.4.1. India
- 5.4.2. China
- 5.4.3. Japan
- 5.4.4. Australia
- 5.4.5. Vietnam
- 5.4.6. South Korea
- 5.4.7. Indonesia
- 5.4.8. Philippines
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Type
6.2. By Technology
6.3. By Probe Type
6.4. By Application
6.5. By End-user
6.6. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis - Volume and Value
7.3. Supply/Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trial
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Illumina, Inc.,
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. Thermo Fisher Scientific Inc.
13.3. Bio-Techne Corporation
13.4. Agilent Technologies Inc.
13.5. Qiagen NV
13.6. F. Hoffmann-La Roche Ltd
13.7. Merck KGaA
13.8. PerkinElmer Inc.
13.9. Myriad Genetics Inc.
13.10. Leica Biosystems Nussloch GmbH
13.11. Genemed Biotechnologies, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

in situハイブリダイゼーションの世界市場：製品タイプ別、技術別、プローブタイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

In situ Hybridization Market Assessment, By Product Type, By Technology, By Probe Type, By Application, By End-Users, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のIn Situハイブリダイゼーション市場の見通し、2017年～2031年

第5章 世界のIn situハイブリダイゼーション市場の見通し、2017年～2031年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 お問合せと免責事項

List of Tables

List of Figures

Increasing Prevalence of Cancer Cases and Genetic Disorders

Growing Research and Development

Fluorescent in Situ Hybridization (FISH) is Expected to Dominate During Forecast Period

North America to Lead the Global In situ Hybridization Market

Key Players Landscape and Outlook

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global In Situ Hybridization Market Outlook, 2017-2031F

5. Global In situ Hybridization Market Outlook, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のIn Situハイブリダイゼーション市場の見通し、2017年～2031年

第5章世界のIn situハイブリダイゼーション市場の見通し、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章お問合せと免責事項